Collaborations
Q2 Solutions has built relationships with a network of companies that we collaborate with to help drive success for our clinical laboratory service.
Collaborations
Q2 Solutions has built relationships with a network of companies that we collaborate with to help drive success for our clinical laboratory service.
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health.
Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers’ most challenging questions.
Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina’s products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Invitae (formerly ArcherDX) is advancing molecular pathology with a robust technology platform for genetic mutation detection by next-generation sequencing. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and powerful bioinformatics software, the Archer® platform dramatically enhances genetic mutation identification and discovery. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays.
Meso Scale Discovery (MSD®) provides high performance, multiplex-enabled biomarker assays for cytokines, toxicology, neurodegeneration and metabolic disease research. MSD’s assays are used by leading biopharmaceutical and academic researchers in human and animal model studies. Its proprietary electrochemiluminescence (ECL) platform delivers exceptional sensitivity, wide dynamic range and rapid turnaround.
NanoString is a life sciences company focused on cancer research and diagnostics. Proven in over 1,000 peer-reviewed publications, the nCounter® System can combine with 3D biology™ technology to create novel biomarkers. The Prosigna® Breast Cancer Prognostic Gene Signature Assay provides FDA 510(k)-cleared diagnostics with the nCounter Dx Analysis System.
Thermo Fisher Scientific mission is to enable our customers to make the world healthier, cleaner and safer. The company helps customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Its premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
Hµrel Corporation, now part of Visikol, is a world-leading provider of patented, primary hepatocyte-based microlivers and microfluidic cell-based assay platforms. Hµrel’s products are distinctive for their high, stable, and long-enduring levels of metabolic and general cellular competency. Utilizing its patent-pending method of packaging its microlivers for “warm” intercontinental air shipment, Hµrel delivers its products to pharmaceutical and biotech researchers worldwide. Hµrel also offers in vitro safety- and DMPK-directed contract research services based on its microliver products.
